Status:
UNKNOWN
Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Schizophrenia
Apathy
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Schizophrenia is a mental pathology that concerns 1% of the French population, characterized by heterogeneity of symptoms. One of them, apathy is defined as a multidimensional psychopathological state...
Eligibility Criteria
Inclusion
- Age ≥ 18 and \< 60 years old
- Diagnosis of schizophrenia according to DSM 5 criteria.
- Score greater than or equal to -18 on the Lille Apathy Rating Scale
- Ability to understand and speak French.
- Obligation to belong to or be a beneficiary of a social security scheme.
- Signature of the consent. If the participant has a representative, signature by the representative.
Exclusion
- History of head injuries or neurological pathologies.
- Current treatment with sismotherapy or repetitive Transcranial Magnetic Stimulation (rTMS).
- Treatment targeted at and/or influencing negative symptoms (CBT, cognitive remediation), or therapeutic trial.
- Participant under safeguard of justice.
- Pregnant or breastfeeding woman.
Key Trial Info
Start Date :
February 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04781179
Start Date
February 22 2022
End Date
September 1 2023
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montpellier University Hospital
Montpellier, France, 34295